The Urokinase Plasminogen Activator System in Metastatic Papillary Thyroid Carcinoma: A Potential Therapeutic Target

被引：3
|
作者：
Nowicki, Theodore S. [1 ]
Moscatello, Augustine L. [2 ]
Shin, Edward [2 ]
Schantz, Stimson [2 ]
Tiwari, Raj K. [1 ,2 ]
Geliebter, Jan [1 ,2 ]
机构：
[1] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Otolaryngol, Valhalla, NY 10595 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2011年 / 96卷 / 10期
关键词：
KINASE INHIBITORS; DISCOVERY; INVASION; CANCER; UPAR;
D O I：
10.1210/jc.2011-1123
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3062 / 3064
页数：3
相关论文
共 50 条
  • [41] N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
    Belfiore, Lisa
    Saunders, Darren N.
    Ranson, Marie
    Vine, Kara L.
    PHARMACEUTICS, 2020, 12 (07) : 1 - 16
  • [42] Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke
    Kadir, Rais Reskiawan A.
    Bayraktutan, Ulvi
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2020, 40 (03) : 347 - 355
  • [43] METASTATIC PAPILLARY CARCINOMA OF THE THYROID TO THE ESOPHAGUS
    LEE, M
    MUNOZ, J
    DUKE, EE
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 (04) : 333 - 334
  • [44] Urokinase-type plasminogen activator: a new target for male contraception
    Qin, Ying
    Han, Yan
    Xiong, Cheng-Liang
    Li, Hong-Gang
    Hu, Lian
    Zhang, Ling
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (02) : 269 - 273
  • [45] Eyelid Metastatic Thyroid Papillary Carcinoma
    Mudhar, Hardeep Singh
    Nuruddin, Murtuza
    Roy, Soma Rani
    OCULAR ONCOLOGY AND PATHOLOGY, 2016, 2 (03) : 156 - 159
  • [46] The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
    Mazar, AP
    ANTI-CANCER DRUGS, 2001, 12 (05) : 387 - 400
  • [47] Urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in small cell carcinoma of the lung and non-small cell carcinoma of the lung
    Wajima, T
    VonHoff, DD
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2264 - P2264
  • [48] In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval
    Ulisse, Salvatore
    Baldini, Enke
    Sorrenti, Salvatore
    Barollo, Susi
    Prinzi, Natalie
    Catania, Antonio
    Nesca, Angela
    Gnessi, Lucio
    Pelizzo, Maria R.
    Mian, Caterina
    De Vito, Corrado
    Calvanese, Anna
    Palermo, Silvio
    Persechino, Severino
    De Antoni, Enrico
    D'Armiento, Massimino
    CLINICAL ENDOCRINOLOGY, 2012, 77 (05) : 780 - 786
  • [49] Characterization of the murine plasminogen/urokinase-type plasminogen-activator system
    Lijnen, HR
    VanHoff, B
    Collen, D
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 241 (03): : 840 - 848
  • [50] Identification of potential therapeutic targets for papillary thyroid carcinoma by bioinformatics analysis
    Zhao, Ming
    Wang, Ke-Jing
    Tan, Zhuo
    Zheng, Chuan-Ming
    Liang, Zhong
    Zhao, Jian-Qiang
    ONCOLOGY LETTERS, 2016, 11 (01) : 51 - 58
12345